Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Radiat Oncol Biol Phys ; 84(4): 902-9, 2012 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-22494590

RESUMO

PURPOSE: Damage to heart and lung from breast radiotherapy is associated with increased cardiovascular mortality and lung cancer development. We conducted a prospective study to evaluate which position is best to spare lung and heart from radiotherapy exposure. METHODS AND MATERIALS: One hundred consecutive Stage 0-IIA breast cancer patients consented to participate in a research trial that required two computed tomography simulation scans for planning both supine and prone positions. The optimal position was defined as that which best covered the contoured breast and tumor bed while it minimized critical organ irradiation, as quantified by the in-field heart and lung volume. The trial was designed to plan the first 100 patients in each position to study correlations between in-field volumes of organs at risk and dose. RESULTS: Fifty-three left and 47 right breast cancer patients were consecutively accrued to the trial. In all patients, the prone position was optimal for sparing lung volume compared to the supine setup (mean lung volume reduction was 93.5 cc for right and 103.6 cc for left breast cancer patients). In 46/53 (87%) left breast cancer patients best treated prone, in-field heart volume was reduced by a mean of 12 cc and by 1.8 cc for the other 7/53 (13%) patients best treated supine. As predicted, supine-prone differences in in-field volume and mean dose of heart and lung were highly correlated (Spearman's correlation coefficient for left breast cancer patients was 0.90 for heart and 0.94 for lung and 0.92 for right breast cancer patients for lung). CONCLUSIONS: Prone setup reduced the amount of irradiated lung in all patients and reduced the amount of heart volume irradiated in 87% of left breast cancer patients. In-field organ volume is a valid surrogate for predicting dose; the trial continued to the planned target of 400.


Assuntos
Neoplasias da Mama/radioterapia , Posicionamento do Paciente/métodos , Mama/anatomia & histologia , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/patologia , Fracionamento da Dose de Radiação , Feminino , Marcadores Fiduciais , Coração/diagnóstico por imagem , Coração/efeitos da radiação , Humanos , Pulmão/diagnóstico por imagem , Pulmão/efeitos da radiação , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Tamanho do Órgão , Órgãos em Risco/diagnóstico por imagem , Órgãos em Risco/efeitos da radiação , Decúbito Ventral , Estudos Prospectivos , Lesões por Radiação/prevenção & controle , Planejamento da Radioterapia Assistida por Computador/métodos , Radioterapia de Intensidade Modulada/métodos , Decúbito Dorsal , Tomografia Computadorizada por Raios X , Carga Tumoral
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa